Skip to main content
. 2021 Jun 18;23(6):941–951. doi: 10.1007/s11307-021-01621-0

Fig. 2.

Fig. 2.

(a) Representative PET/CT images at 22 h post-injection of 89Zr-Df-IAB22M2C on day 9: 1 mg/kg isotype treated (PF-07069699, left) and GUCY2C BsAb treated (PF-07062119, right), with respective CD8+ T staining (brown; IHC, scale bar equal 50 μm). (b) Representative PET/CT images at 22 h post-injection of 89Zr-Df-IAB22M2C exploring differences in temporal and dose response effects.